Trial Profile
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Avonex in Subjects With Moderate to Severe Ulcerative Colitis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Mar 2017
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Biogen
- 28 Jul 2011 Planned end date changed from 1 Feb 2010 to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 28 Jul 2011 Planned end date changed from 1 Feb 2010 to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 20 Oct 2010 Safety results were presented at the 75th Annual Scientific Meeting of the American College of Gastroenterology.